1 Introduction to Research & Analysis Reports
    1.1 T-Cell Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global T-Cell Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global T-Cell Therapy Overall Market Size
    2.1 Global T-Cell Therapy Market Size: 2021 VS 2027
    2.2 Global T-Cell Therapy Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top T-Cell Therapy Players in Global Market
    3.2 Top Global T-Cell Therapy Companies Ranked by Revenue
    3.3 Global T-Cell Therapy Revenue by Companies
    3.4 Top 3 and Top 5 T-Cell Therapy Companies in Global Market, by Revenue in 2020
    3.5 Global Companies T-Cell Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 T-Cell Therapy Players in Global Market
        3.6.1 List of Global Tier 1 T-Cell Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 T-Cell Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global T-Cell Therapy Market Size Markets, 2021 & 2027
        4.1.2 CAR T Cell Therapy
        4.1.3 TCR Therapy
        4.1.4 TIL Therapy
    4.2 By Type - Global T-Cell Therapy Revenue & Forecasts
        4.2.1 By Type - Global T-Cell Therapy Revenue, 2016-2021
        4.2.2 By Type - Global T-Cell Therapy Revenue, 2022-2027
        4.2.3 By Type - Global T-Cell Therapy Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global T-Cell Therapy Market Size, 2021 & 2027
        5.1.2 Hospitals
        5.1.3 Clinics & Ambulatory Centers
        5.1.4 Cancer Research Institutes
        5.1.5 Others
    5.2 By Application - Global T-Cell Therapy Revenue & Forecasts
        5.2.1 By Application - Global T-Cell Therapy Revenue, 2016-2021
        5.2.2 By Application - Global T-Cell Therapy Revenue, 2022-2027
        5.2.3 By Application - Global T-Cell Therapy Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global T-Cell Therapy Market Size, 2021 & 2027
    6.2 By Region - Global T-Cell Therapy Revenue & Forecasts
        6.2.1 By Region - Global T-Cell Therapy Revenue, 2016-2021
        6.2.2 By Region - Global T-Cell Therapy Revenue, 2022-2027
        6.2.3 By Region - Global T-Cell Therapy Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America T-Cell Therapy Revenue, 2016-2027
        6.3.2 US T-Cell Therapy Market Size, 2016-2027
        6.3.3 Canada T-Cell Therapy Market Size, 2016-2027
        6.3.4 Mexico T-Cell Therapy Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe T-Cell Therapy Revenue, 2016-2027
        6.4.2 Germany T-Cell Therapy Market Size, 2016-2027
        6.4.3 France T-Cell Therapy Market Size, 2016-2027
        6.4.4 U.K. T-Cell Therapy Market Size, 2016-2027
        6.4.5 Italy T-Cell Therapy Market Size, 2016-2027
        6.4.6 Russia T-Cell Therapy Market Size, 2016-2027
        6.4.7 Nordic Countries T-Cell Therapy Market Size, 2016-2027
        6.4.8 Benelux T-Cell Therapy Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia T-Cell Therapy Revenue, 2016-2027
        6.5.2 China T-Cell Therapy Market Size, 2016-2027
        6.5.3 Japan T-Cell Therapy Market Size, 2016-2027
        6.5.4 South Korea T-Cell Therapy Market Size, 2016-2027
        6.5.5 Southeast Asia T-Cell Therapy Market Size, 2016-2027
        6.5.6 India T-Cell Therapy Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America T-Cell Therapy Revenue, 2016-2027
        6.6.2 Brazil T-Cell Therapy Market Size, 2016-2027
        6.6.3 Argentina T-Cell Therapy Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa T-Cell Therapy Revenue, 2016-2027
        6.7.2 Turkey T-Cell Therapy Market Size, 2016-2027
        6.7.3 Israel T-Cell Therapy Market Size, 2016-2027
        6.7.4 Saudi Arabia T-Cell Therapy Market Size, 2016-2027
        6.7.5 UAE T-Cell Therapy Market Size, 2016-2027
7 Players Profiles
    7.1 Gilead Sciences, Inc.
        7.1.1 Gilead Sciences, Inc. Corporate Summary
        7.1.2 Gilead Sciences, Inc. Business Overview
        7.1.3 Gilead Sciences, Inc. T-Cell Therapy Major Product Offerings
        7.1.4 Gilead Sciences, Inc. T-Cell Therapy Revenue in Global (2016-2021)
        7.1.5 Gilead Sciences, Inc. Key News
    7.2 Sorrento Therapeutics
        7.2.1 Sorrento Therapeutics Corporate Summary
        7.2.2 Sorrento Therapeutics Business Overview
        7.2.3 Sorrento Therapeutics T-Cell Therapy Major Product Offerings
        7.2.4 Sorrento Therapeutics T-Cell Therapy Revenue in Global (2016-2021)
        7.2.5 Sorrento Therapeutics Key News
    7.3 Fate Therapeutics Inc.
        7.3.1 Fate Therapeutics Inc. Corporate Summary
        7.3.2 Fate Therapeutics Inc. Business Overview
        7.3.3 Fate Therapeutics Inc. T-Cell Therapy Major Product Offerings
        7.3.4 Fate Therapeutics Inc. T-Cell Therapy Revenue in Global (2016-2021)
        7.3.5 Fate Therapeutics Inc. Key News
    7.4 Novartis International AG
        7.4.1 Novartis International AG Corporate Summary
        7.4.2 Novartis International AG Business Overview
        7.4.3 Novartis International AG T-Cell Therapy Major Product Offerings
        7.4.4 Novartis International AG T-Cell Therapy Revenue in Global (2016-2021)
        7.4.5 Novartis International AG Key News
    7.5 AbbVie Inc.
        7.5.1 AbbVie Inc. Corporate Summary
        7.5.2 AbbVie Inc. Business Overview
        7.5.3 AbbVie Inc. T-Cell Therapy Major Product Offerings
        7.5.4 AbbVie Inc. T-Cell Therapy Revenue in Global (2016-2021)
        7.5.5 AbbVie Inc. Key News
    7.6 Adaptimmune Therapeutics PLC
        7.6.1 Adaptimmune Therapeutics PLC Corporate Summary
        7.6.2 Adaptimmune Therapeutics PLC Business Overview
        7.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Major Product Offerings
        7.6.4 Adaptimmune Therapeutics PLC T-Cell Therapy Revenue in Global (2016-2021)
        7.6.5 Adaptimmune Therapeutics PLC Key News
    7.7 Bluebird Bio
        7.7.1 Bluebird Bio Corporate Summary
        7.7.2 Bluebird Bio Business Overview
        7.7.3 Bluebird Bio T-Cell Therapy Major Product Offerings
        7.4.4 Bluebird Bio T-Cell Therapy Revenue in Global (2016-2021)
        7.7.5 Bluebird Bio Key News
    7.8 TCR2 Therapeutics, Inc.
        7.8.1 TCR2 Therapeutics, Inc. Corporate Summary
        7.8.2 TCR2 Therapeutics, Inc. Business Overview
        7.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Major Product Offerings
        7.8.4 TCR2 Therapeutics, Inc. T-Cell Therapy Revenue in Global (2016-2021)
        7.8.5 TCR2 Therapeutics, Inc. Key News
    7.9 Pfizer Inc.
        7.9.1 Pfizer Inc. Corporate Summary
        7.9.2 Pfizer Inc. Business Overview
        7.9.3 Pfizer Inc. T-Cell Therapy Major Product Offerings
        7.9.4 Pfizer Inc. T-Cell Therapy Revenue in Global (2016-2021)
        7.9.5 Pfizer Inc. Key News
    7.10 DiaCarta, Inc.
        7.10.1 DiaCarta, Inc. Corporate Summary
        7.10.2 DiaCarta, Inc. Business Overview
        7.10.3 DiaCarta, Inc. T-Cell Therapy Major Product Offerings
        7.10.4 DiaCarta, Inc. T-Cell Therapy Revenue in Global (2016-2021)
        7.10.5 DiaCarta, Inc. Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer